Vimarsana
Biggest News Aggregation in the World

Page 13 - Vida Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vida Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vida Ventures Today - Breaking & Trending Today

A brand new nine-story building at 100 Forge in Watertown is now fully leased - Vimarsana News

A brand new nine-story building at 100 Forge in Watertown is now fully leased

Boylston Properties announces 100 Forge in Watertown is now fully leased to five life science companies.

A2 Bio to Highlight Program Updates in Two Presentations at SITC 2021 - Vimarsana News

A2 Bio to Highlight Program Updates in Two Presentations at SITC 2021

/PRNewswire/ -- A2 Biotherapeutics, Inc., "A2 Bio", is a biotechnology company focused on the development of first-in-class T cell therapies to treat solid...

ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs - Vimarsana News

ReCode Therapeutics gets $80M to deliver on new RNA therapies for the lungs

ReCode Therapeutics closed an $80 million Series B round of financing that included Pfizer and Sanofi as investors. The startup’s technology uses lipid nanoparticles to deliver genetic medicines, and its two lead programs are for rare lung disorders.

Vigil bags $90M to take ex-Amgen assets on path from rare diseases to Alzheimer's - Vimarsana News

Vigil bags $90M to take ex-Amgen assets on path from rare diseases to Alzheimer's

Vigil Neuroscience is barreling forward with a strategy that will see it hop along steppingstones from rare diseases to Alzheimer’s. Having emerged with $50 million late last year, Vigil has gathered up an additional $90 million to validate its ex-Amgen asset in a rare, inherited neurodegenerative disease.

Centessa raises $330M in third largest biotech IPO this year - Vimarsana News

Centessa raises $330M in third largest biotech IPO this year

BioPharma